Deakin University
Browse

File(s) not publicly available

A randomized phase 2, single-blind study of temozolomide (TMZ) and radiotherapy (RT) combined with nivolumab or placebo (PBO) in newly diagnosed adult patients (pts) with tumor O6-methylguanine DNA methyltransferase (MGMT)-methylated glioblastoma (GBM)—CheckMate-548

journal contribution
posted on 2016-10-01, 00:00 authored by M Weller, G Vlahovic, Mustafa Khasraw, A A Brandes, R Zwirtes, K Tatsuoka, A F Carpentier, D A Reardon, M Bent
A randomized phase 2, single-blind study of temozolomide (TMZ) and radiotherapy (RT) combined with nivolumab or placebo (PBO) in newly diagnosed adult patients (pts) with tumor O6-methylguanine DNA methyltransferase (MGMT)-methylated glioblastoma (GBM)—CheckMate-548

History

Journal

Annals of Oncology

Volume

27

Pagination

vi113 - ?

ISSN

0923-7534

eISSN

1569-8041

Publication classification

E3 Extract of paper

Usage metrics

    Research Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC